Literature DB >> 2188478

Insulin sensitivity in patients with anorexia nervosa and bulimia.

N Kiriike1, S Nishiwaki, T Nagata, Y Okuno, J Yamada, S Tanaka, A Fujii, Y Kawakita.   

Abstract

Insulin sensitivity was studied using the euglycemic insulin clamp technique in 5 female patients with anorexia nervosa and 4 females with bulimia. The results were compared with those of 15 male patients with non-insulin-dependent diabetes mellitus. Euglycemic insulin clamp is performed for 2 h using the Biostator, during which time insulin was infused at a rate of 0.77 mU kg-1 min-1. Fasting plasma glucose and immunoreactive insulin tended to be lower in patients with anorexia nervosa than in those with bulimia (69.8 +/- 6.7 vs 75.9 +/- 7.7 mg/dl, and 5.9 +/- 2.0 vs 9.8 +/- 3.4 U/ml). The mean metabolic clearance rate (MCR) was 9.2 +/- 3.9 ml kg-1 min-1 for patients with anorexia nervosa, 5.1 +/- 2.2 ml kg-1 min-1 for patients with bulimia, and 3.8 +/- 0.3 ml kg-1 min-1 for patients with diabetes mellitus. However, one anorectic had a significantly high MCR. One anorectic and 3 bulimics had a significantly low MCR. These results suggest that insulin sensitivity varied in patients with anorexia nervosa, whereas it tended to decrease in some patients with bulimia but not to the same degree as in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188478     DOI: 10.1111/j.1600-0447.1990.tb06487.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse.

Authors:  Jackie A Fretz; Tracy Nelson; Yougen Xi; Douglas J Adams; Clifford J Rosen; Mark C Horowitz
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

2.  Plasma leptin levels, insulin secretion, clearance and action on glucose metabolism in anorexia nervosa.

Authors:  M R Letiexhe; A J Scheen; P J Lefèbvre
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.